| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.9 |
| Acute Respiratory Distress Syndrome |
0 |
0.13 |
| Fatigue |
0 |
0.12 |
| Pain Management |
0 |
0.09 |
| Blood |
0 |
0.08 |
| Brain |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Severe Acute Respiratory Syndrome |
0 |
0.08 |
| Headache |
0 |
0.07 |
| Myalgia |
0 |
0.07 |
| Type 2 Diabetes Mellitus |
0 |
0.07 |
| Anxiety |
0 |
0.04 |
| Anxiety Disorder |
0 |
0.04 |
| Child |
0 |
0.04 |
| Depression |
0 |
0.04 |
| Diversity |
0 |
0.04 |
| Epstein-Barr Virus |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Insomnia |
0 |
0.04 |
| Intubation |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Muscle |
0 |
0.04 |
| Nail |
0 |
0.04 |
| Organ Failure |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.04 |
| Sleep Disorders |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Statistics |
0 |
0.04 |
| Texas |
0 |
0.04 |
| Vaccines |
0 |
0.04 |